Mucin 18‐targeted humanized monoclonal antibody immune positron emission tomography imaging and patient‐derived tumor xenograft visualization
Authors:
Open Access
Abstract
In the context of precision diagnosis for various subtypes of melanoma, identifying biomarkers with clinical translational potential from a molecular standpoint is crucial for a more comprehensive characterization of the disease. Mucin 18 (MUC18) is highly expressed in both tumor cells and tumor vasculature in major melanoma subtypes and is restricted to normal tissues. A noninvasive imaging approach for MUC18 in melanoma utilizing an immune positron emission tomography (PET) radionuclide‐conjugated drug (RDC) with an 89Zr‐labeled humanized anti‐MUC18 monoclonal antibody (mAb) was developed. A375, Sk‐Mel‐28, HMVII, and A549 cells and tumor model mice were conducted. Immuno‐PET was employed to assess the specificity and targeting of three distinct melanoma cell line‐derived xenografts (CDXs) and patient‐derived tumor xenografts (PDXs) in immunodeficient mice. The developed RDC, named 89Zr‐IP150, demonstrated robust in vitro stability and high binding affinity, ensuring reliable and specific PET imaging of small, medium, and large subcutaneous tumors in human melanoma mouse xenotransplantation models. Notably, for the first time, the clinical translational potential of 89Zr‐IP150 was successfully validated using PDX models. These findings present a noninvasive, real‐time method for the early screening of MUC18 (+) melanoma patients and are important for studying the early‐stage biological distribution of MUC18‐targeted antibody‐drug conjugates.Keywords
This publication has 38 references indexed in Scilit:
- CD146 Associates with Gp130 to Control a Macrophage Pro‐inflammatory Program That Regulates the Metabolic Response to ObesityAdvanced Science, 2022
- Long axial field of view PET scanners: a road map to implementation and new possibilitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- CD146‐Targeted Multimodal Image‐Guided Photoimmunotherapy of MelanomaAdvanced Science, 2019
- Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitorEuropean Journal of Cancer, 2018
- ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Melanoma epidemiology, biology and prognosisEuropean Journal of Cancer Supplements, 2013
- CD146, a multi-functional molecule beyond adhesionCancer Letters, 2013
- CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomyInternational Urology and Nephrology, 2012
- Critical roles of CD146 in zebrafish vascular developmentDevelopmental Dynamics, 2004